2021
DOI: 10.1177/20363613211007792
|View full text |Cite
|
Sign up to set email alerts
|

Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis

Abstract: A case of pheochromocytoma producing vasoactive intestinal peptide (VIP) and left ventricular thrombus in the absence of cardiomyopathy or wall motion abnormalities on echocardiogram is presented along with a review of the relevant literature. A 30-year-old female of Afghani descent with past medical history of panic attacks presented with fever, cough, sore throat, vomiting, and was found to have an 11 cm adrenal mass consistent with primary adrenocortical adenoma versus carcinoma. Her tumor elicited catechol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…It is possible that the vasodilatory effects of VIP “masked” the hypertensive effects of catecholamines, potentially delaying diagnosis. There were no reports of associations with other endocrinopathies, and only 1 case (in the study by Hermel et al 5 ) reported a family history positive for an aunt with thyroid disease. Genetic testing was reported in 4 cases (in the studies by Negro et al 6 , Jiang et al 8 , Leibowitz-Amit et al 9 , and Ozbay et al 11 ), of which only 1 (in the study by Negro et al 6 ) reported a “synonymous single nucleotide variant of the SDHA gene” associated with “probably benign pheochromocytoma.” In localized disease, surgical resection is generally definitive with good prognosis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is possible that the vasodilatory effects of VIP “masked” the hypertensive effects of catecholamines, potentially delaying diagnosis. There were no reports of associations with other endocrinopathies, and only 1 case (in the study by Hermel et al 5 ) reported a family history positive for an aunt with thyroid disease. Genetic testing was reported in 4 cases (in the studies by Negro et al 6 , Jiang et al 8 , Leibowitz-Amit et al 9 , and Ozbay et al 11 ), of which only 1 (in the study by Negro et al 6 ) reported a “synonymous single nucleotide variant of the SDHA gene” associated with “probably benign pheochromocytoma.” In localized disease, surgical resection is generally definitive with good prognosis.…”
Section: Discussionmentioning
confidence: 99%
“…The rare case of a VIP-secreting pheochromocytoma was first reported in 1975 by Loehry et al 4 , and since this time, only approximately 25 cases have been described. 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 We describe a case of a man found to have a pheochromocytoma who presented with hypertensive emergency and WDHA syndrome, resolved with adrenalectomy.…”
Section: Introductionmentioning
confidence: 98%